IDE and type 2 diabetes mellitus: In line with this, Li et al. (2018) demonstrated that an animal model presenting both T2D and AD exhibits accelerated neurodegeneration and cognitive impairment, in association with dysregulation of the insulin degrading enzyme (IDE) expression.